Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

BACKGROUND: Evaluation of cardiovascular prognosis in patients with stable coronary heart disease is based on clinical characteristics and biomarkers indicating dysglycemia, dyslipidemia, renal dysfunction, and possibly cardiac dysfunction. Inflammation plays a key role in atherosclerosis, but the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Held, Claes, White, Harvey D., Stewart, Ralph A. H., Budaj, Andrzej, Cannon, Christopher P., Hochman, Judith S., Koenig, Wolfgang, Siegbahn, Agneta, Steg, Philippe Gabriel, Soffer, Joseph, Weaver, W. Douglas, Östlund, Ollie, Wallentin, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721818/
https://www.ncbi.nlm.nih.gov/pubmed/29066452
http://dx.doi.org/10.1161/JAHA.116.005077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721818/
https://www.ncbi.nlm.nih.gov/pubmed/29066452
http://dx.doi.org/10.1161/JAHA.116.005077

Ejemplares similares